| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 00:03:40 UTC |
|---|
| Update Date | 2021-09-26 22:56:29 UTC |
|---|
| HMDB ID | HMDB0247043 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | 6-Chloro-2,3,4,5-tetrahydro-1H-3-benzazepine |
|---|
| Description | 6-Chloro-2,3,4,5-tetrahydro-1H-3-benzazepine, also known as SK and F 101055, belongs to the class of organic compounds known as benzazepines. These are organic compounds containing a benzene ring fused to an azepine ring (unsaturated seven-membered heterocycle with one nitrogen atom replacing a carbon atom). Based on a literature review very few articles have been published on 6-Chloro-2,3,4,5-tetrahydro-1H-3-benzazepine. This compound has been identified in human blood as reported by (PMID: 31557052 ). 6-chloro-2,3,4,5-tetrahydro-1h-3-benzazepine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 6-Chloro-2,3,4,5-tetrahydro-1H-3-benzazepine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | InChI=1S/C10H12ClN/c11-10-3-1-2-8-4-6-12-7-5-9(8)10/h1-3,12H,4-7H2 |
|---|
| Synonyms | | Value | Source |
|---|
| SK And F 101055 | HMDB | | SK And F 101055 hydrochloride | HMDB | | SK And F-101055 | HMDB |
|
|---|
| Chemical Formula | C10H12ClN |
|---|
| Average Molecular Weight | 181.66 |
|---|
| Monoisotopic Molecular Weight | 181.0658271 |
|---|
| IUPAC Name | 6-chloro-2,3,4,5-tetrahydro-1H-3-benzazepine |
|---|
| Traditional Name | 6-chloro-benzazepine |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | ClC1=CC=CC2=C1CCNCC2 |
|---|
| InChI Identifier | InChI=1S/C10H12ClN/c11-10-3-1-2-8-4-6-12-7-5-9(8)10/h1-3,12H,4-7H2 |
|---|
| InChI Key | KGJFKHNSLOSGMN-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzazepines. These are organic compounds containing a benzene ring fused to an azepine ring (unsaturated seven-membered heterocycle with one nitrogen atom replacing a carbon atom). |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzazepines |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Benzazepines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Benzazepine
- Azepine
- Aralkylamine
- Benzenoid
- Aryl halide
- Aryl chloride
- Azacycle
- Secondary amine
- Secondary aliphatic amine
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Organic nitrogen compound
- Amine
- Hydrocarbon derivative
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 10.1226 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.02 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 925.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 326.6 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 130.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 197.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 92.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 323.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 342.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 463.8 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 816.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 341.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 966.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 229.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 277.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 443.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 276.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 15.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 6-Chloro-2,3,4,5-tetrahydro-1H-3-benzazepine,1TMS,isomer #1 | C[Si](C)(C)N1CCC2=CC=CC(Cl)=C2CC1 | 1747.0 | Semi standard non polar | 33892256 | | 6-Chloro-2,3,4,5-tetrahydro-1H-3-benzazepine,1TMS,isomer #1 | C[Si](C)(C)N1CCC2=CC=CC(Cl)=C2CC1 | 1754.2 | Standard non polar | 33892256 | | 6-Chloro-2,3,4,5-tetrahydro-1H-3-benzazepine,1TMS,isomer #1 | C[Si](C)(C)N1CCC2=CC=CC(Cl)=C2CC1 | 2157.3 | Standard polar | 33892256 | | 6-Chloro-2,3,4,5-tetrahydro-1H-3-benzazepine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCC2=CC=CC(Cl)=C2CC1 | 1958.0 | Semi standard non polar | 33892256 | | 6-Chloro-2,3,4,5-tetrahydro-1H-3-benzazepine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCC2=CC=CC(Cl)=C2CC1 | 2012.0 | Standard non polar | 33892256 | | 6-Chloro-2,3,4,5-tetrahydro-1H-3-benzazepine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1CCC2=CC=CC(Cl)=C2CC1 | 2346.7 | Standard polar | 33892256 |
|
|---|